Crinetics Pharmaceuticals, Inc. (CRNX)
37.70
+0.47
(+1.26%)
USD |
NASDAQ |
Apr 06, 16:00
37.42
-0.28
(-0.74%)
Pre-Market: 09:12
Crinetics Pharmaceuticals SG&A Expense (TTM) : 191.33M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Plus Therapeutics, Inc. | 12.13M |
| Nektar Therapeutics | 68.67M |
| Madrigal Pharmaceuticals, Inc. | 813.83M |
| Axsome Therapeutics, Inc. | 570.60M |
| Gossamer Bio, Inc. | 37.63M |